Ketamine injections tested as new treatment for long COVID brain fog
NCT ID NCT06821087
First seen Dec 29, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This pilot study tests whether low-dose ketamine can reduce fatigue and improve thinking in people with Long COVID. Twenty adults aged 18-65 with ongoing tiredness or brain fog will receive four ketamine injections over two weeks. Researchers will track symptom changes, brain scans, and safety to see if this approach offers relief.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Health Austin
Austin, Texas, 78712, United States
Conditions
Explore the condition pages connected to this study.